▸
▾
Claim This Listing
Please login in order to be able to claim this listing.
You are not currently logged in. Please login or register first. When registering, you will receive an activation email. Be sure to check your spam if you don’t see it in your email within 60 minutes.
Login
UltraSight Ltd.
UltraSight uses the power of AI for real-time guidance of ultrasound cardiac imaging procedures, enabling more accurate and timely clinical decisions.
UltraSight AI Guidance is indicated for use in 2D transthoracic echocardiography for adult patients. Especifically in the acquisition of the following standard views: PLAX, PSA-AV, PSA-MV, PSAX-PM, AP4, AP5, AP2, AP3, SubC4, and SC-IVC.
The product was cleared by the FDA in July of 2023 (https://www.accessdata.fda.gov/cdrh_docs/pdf22/K223347.pdf)
